Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinoma

Clinical trial NCT05013268 · UNKNOWN

Trial details

NCT number: NCT05013268
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Cervical Squamous Cell Carcinoma

Start date: 2021-09-01
Primary completion: 2022-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.